TY - JOUR
T1 - Disclosure of interests and management of conflicts of interest in clinical guidelines and guidance statements
T2 - Methods from the clinical guidelines committee of the American college of physicians
AU - Qaseem, Amir
AU - Wilt, Timothy J.
PY - 2019/9/3
Y1 - 2019/9/3
N2 - One of the hallmarks of a trustworthy clinical guideline or guidance statement is a comprehensive process for disclosure of interests (DOI) and management of conflicts of interest (COIs). The American College of Physicians (ACP) Clinical Guidelines Committee (CGC) aims to disclose all health care-related interests and manage conflicts in a manner that is transparent, proportional, and consistent. Any person involved in the development of an ACP clinical guideline or guidance statement must disclose all financial and intellectual interests related to health care from the previous 3 years. Persons complete disclosures at the start of their participation and are required to update them over the course of their involvement with the CGC, including before each CGC meeting. A DOI-COI Review and Management Panel reviews the disclosures; flags potential conflicts; grades the COI as low-, moderate-, or high-level; and manages the person's participation accordingly. A high-level COI results in recusal from authorship, voting, and all committee discussions. Participants with a moderate-level COI are recused from authorship and voting for clinically relevant topics but may participate in all discussions. A low-level COI results in no role restrictions. All disclosures and COI management decisions are publicly reported.
AB - One of the hallmarks of a trustworthy clinical guideline or guidance statement is a comprehensive process for disclosure of interests (DOI) and management of conflicts of interest (COIs). The American College of Physicians (ACP) Clinical Guidelines Committee (CGC) aims to disclose all health care-related interests and manage conflicts in a manner that is transparent, proportional, and consistent. Any person involved in the development of an ACP clinical guideline or guidance statement must disclose all financial and intellectual interests related to health care from the previous 3 years. Persons complete disclosures at the start of their participation and are required to update them over the course of their involvement with the CGC, including before each CGC meeting. A DOI-COI Review and Management Panel reviews the disclosures; flags potential conflicts; grades the COI as low-, moderate-, or high-level; and manages the person's participation accordingly. A high-level COI results in recusal from authorship, voting, and all committee discussions. Participants with a moderate-level COI are recused from authorship and voting for clinically relevant topics but may participate in all discussions. A low-level COI results in no role restrictions. All disclosures and COI management decisions are publicly reported.
UR - http://www.scopus.com/inward/record.url?scp=85072055950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072055950&partnerID=8YFLogxK
U2 - 10.7326/M18-3279
DO - 10.7326/M18-3279
M3 - Review article
C2 - 31426089
AN - SCOPUS:85072055950
SN - 0003-4819
VL - 171
SP - 354
EP - 361
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 5
ER -